shutterstock.com
Jan 7, 2025, 18:38
Concomitant PPIs and capecitabine-based chemoradiotherapy in rectal cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a recent paper by M. Bridoux et al. published in ESMO GI Oncology:
“Concomitant PPI and capecitabine-based CRT in rectal cancer (data from PRODIGE-23):
- No statistical significant association in survival and pathological response
- 38 patients in PPI group, numerically worse survival tendency.”
Authors: M. Bridoux, E. Aymes, T. Conroy, S. Gourgou, A. Carnot, C. Borg, M.-C. Le Deley, A. Turpin.
More posts featuring Erman Akkus.
Erman Akkus is a medical oncology fellow at Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education at the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 7, 2025, 18:04
Jan 7, 2025, 18:04
Jan 7, 2025, 18:03
Jan 7, 2025, 17:59
Jan 7, 2025, 17:54